Thyrocare News

Thyrocare founder Velumani advocates for keeping UPI free for the next five years, stating it would maintain India's lead in digital payments. This comes as a 0

API Holdings, the parent company of PharmEasy and Thyrocare, reported a narrowed loss of Rs 29.6 crore in Q1 FY27, down from Rs 145.4 crore a year earlier, with

Digital healthcare platform API Holdings, parent company of PharmEasy and Thyrocare, has become debt-free after repaying Rs 1,050 crore, funded by a stake sale

Thyrocare Technologies shares dropped 8% after its promoter, Docon Technologies, sold approximately 1.58 crore shares, reducing its stake from 60.92% to 51.02%.

Block deals worth Rs 1,250 crore saw 8.3% of Thyrocare's equity change hands at a discount, while Urban Company also experienced a 2% equity change.